Ahmet Burak Agaoglu

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study.

|Jun 11, 2026
Prognostic value of the CHAM score in non-small cell lung cancer patients treated with nivolumab.

|Nov 27, 2025
Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer.

Ahmet Burak Agaoglu, Atike Pinar Erdogan, Ferhat Ekinci

|Oct 29, 2025
Survival Benefit of Temozolomide Plus Irinotecan as Second-Line Therapy in Small Cell Lung Cancer: A Retrospective Single-Center Study.

Omer Acar, Ahmet Burak Agaoglu, Mustafa Sahbazlar

|Aug 02, 2025
Clinicopathological Perspectives of Liver Mass Biopsies: A Single Center Experience of 406 Cases.

Ömer Atmış, Hanife Seda Mavili, Fatma Seher Pehlivan

|Jun 17, 2025
Prognostic value of the HALP score in patients with testicular cancer: a retrospective study.

Ahmet Burak Agaoglu, Atike Pınar Erdogan, Mustafa Sahbazlar

Pageof 1

Frequent Collaborators

5 joint publications

Atike Pınar Erdogan

5 joint publications

Ferhat Ekinci

2 joint publications

Mustafa Sahbazlar

2 joint publications

Ertugrul Bayram